|
HY-P70324A-50ug
|
MedChemexpress LLC
|
KEL/Kelch-like 41, Human (HEK293, C-His)
|
|
|
|
|
HY-P70324-10ug
|
MedChemexpress LLC
|
KEL/Kelch-like 41, Human (HEK293, His)
|
|
|
|
|
HY-P70324-50ug
|
MedChemexpress LLC
|
KEL/Kelch-like 41, Human (HEK293, His)
|
|
|
|
|
HY-P2064-500ug
|
MedChemexpress LLC
|
Lariatin A [CAS 732286-09-8]
|
|
|
|
|
HY-P7232A-10ug
|
MedChemexpress LLC
|
Leptin, Human (His)
|
|
|
|
|
HY-P7232A-2ug
|
MedChemexpress LLC
|
Leptin, Human (His)
|
|
|
|
|
HY-P7232A-50ug
|
MedChemexpress LLC
|
Leptin, Human (His)
|
|
|
|
|
HY-P70704A-1mg
|
MedChemexpress LLC
|
Leptin, Mouse (His)
|
|
|
|
|
HY-P70704A-10ug
|
MedChemexpress LLC
|
Leptin, Mouse (His)
|
|
|
|
|
HY-P70704A-100ug
|
MedChemexpress LLC
|
Leptin, Mouse (His)
|
|
|
|
|
HY-P70704A-2ug
|
MedChemexpress LLC
|
Leptin, Mouse (His)
|
|
|
|
|
HY-P70704A-50ug
|
MedChemexpress LLC
|
Leptin, Mouse (His)
|
|
|
|
|
HY-P70704A-500ug
|
MedChemexpress LLC
|
Leptin, Mouse (His)
|
|
|
|
|
HY-W011165-100mg
|
MedChemexpress LLC
|
L-Lysyl-L-lysine (dihydrochloride) [CAS 52123-30-5]
|
|
|
|
|
HY-W011165-250mg
|
MedChemexpress LLC
|
L-Lysyl-L-lysine (dihydrochloride) [CAS 52123-30-5]
|
|
|
|
|
HY-W087027-100mg
|
MedChemexpress LLC
|
Maleimide-NOTA [CAS 1295584-83-6]
|
|
Cancer-programmed cell death
|
|
|
HY-W087027-25mg
|
MedChemexpress LLC
|
Maleimide-NOTA [CAS 1295584-83-6]
|
|
Cancer-programmed cell death
|
|
|
HY-W087027-50mg
|
MedChemexpress LLC
|
Maleimide-NOTA [CAS 1295584-83-6]
|
|
Cancer-programmed cell death
|
|
|
HY-P70364-10ug
|
MedChemexpress LLC
|
METAP2/Methionine aminopeptidase 2, Human (Sf9, His)
|
|
|
|
|
HY-P70364-50ug
|
MedChemexpress LLC
|
METAP2/Methionine aminopeptidase 2, Human (Sf9, His)
|
|
|
|
|
HY-P72876-10ug
|
MedChemexpress LLC
|
MME, Human (HEK293)
|
|
|
|
|
HY-P72876-100ug
|
MedChemexpress LLC
|
MME, Human (HEK293)
|
|
|
|
|
HY-P72876-5ug
|
MedChemexpress LLC
|
MME, Human (HEK293)
|
|
|
|
|
HY-P72876-50ug
|
MedChemexpress LLC
|
MME, Human (HEK293)
|
|
|
|
|
HY-P72505-10ug
|
MedChemexpress LLC
|
MME, Human (HEK293, His, Solution)
|
|
|
|
